Evidence map›Paper›PMID 39611805›Full record

ArticleJournal of applied clinical medical physics2025

CT-based whole lung radiomics nomogram to identify middle-aged and elderly COVID-19 patients at high risk of progressing to critical disease.

Xin'ang Jiang, Jun Hu, Qinling Jiang, Taohu Zhou, Fei Yao, Yi Sun, Chao Zhou, Qianyun Ma, Jingyi Zhao, Kang Shi and 6 more

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xin'ang JiangDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Jun HuDepartment of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Qinling JiangDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Taohu ZhouDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Fei YaoDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Yi SunDepartment of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Chao ZhouDepartment of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Qianyun MaDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Jingyi ZhaoDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Kang ShiDepartment of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Wen YangDepartment of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Xiuxiu ZhouDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Yun WangDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Shiyuan LiuDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Xiaoyan XinDepartment of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Li FanDepartment of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.ORCID https://orcid.org/0000-0003-4722-3933

Funding

Clinical Innovative Project of Shanghai Changzheng Hospital 2020YLCYJ-Y24Medical imaging database construction program of National Health Comission YXFSC2022JJSJ002National Key Research and Development Program of China 2022YFC2010000National Key Research and Development Program of China 2022YFC2010002National Natural Science Foundation of China 81930049National Natural Science Foundation of China 82171926Program of Science and Technology Commission of Shanghai Municipality 19411951300Program of Science and Technology Commission of Shanghai Municipality 21DZ2202600
6 · The paper itself

Abstract

backgroundCOVID-19 remains widespread and poses a threat to people's physical and mental health, especially middle-aged and elderly individuals. Early identification of COVID-19 patients at high risk of progressing to critical disease helps improve overall patient outcomes and healthcare efficiency. PURPOSE: To develop a radiomics nomogram to predict the risk of newly admitted middle-aged and elderly COVID-19 patients progressing to critical disease.

methodsA total of 794 patients (aged 40 years or above) were retrospectively included in the study from two institutions, all of them were with non-critical COVID-19 on admission. At follow-up, patients were divided into non-critical group and critical group. About 443 patients (384 non-critical and 59 critical) from the first hospital were randomly assigned to the training (n = 311) and internal validation (n = 132) set in a 7:3 ratio. Additionally, an independent external cohort of 351 patients (292 non-critical and 59 critical) from another hospital was evaluated. Radiomics signatures and clinical indicators were used to build a radiomics model and a clinical model after computed tomography (CT) image processing, CT whole-lung segmentation, feature extraction, and feature selection. The radiomics nomogram model integrated radiomics model and clinical model. The receiver operating characteristic curve (AUC) was used to assess the performance of the proposed models. Calibration curves and decision curve analysis were used to assess the performance of the radiomics nomogram.

resultsFor the training, internal validation, and external validation sets, the AUC values of the radiomic nomogram for the prediction of COVID-19 progression were 0.916, 0.917, and 0.890, respectively. Calibration curves indicated that there was no significant departure between prediction and observation in three sets. The decision curve image demonstrated the clinical utility of the nomogram model.

conclusionsOur nomogram model incorporates radiomics features and clinical indicators, it provides a new pathway to increase predictive accuracy or clinical utility, further helping to provide personalized management for middle-aged and elderly patients with COVID-19.

Indexed as

COVID-19LungNomogramsTomography, X-Ray ComputedAdultAgedAged, 80 and overCritical IllnessDisease ProgressionFemaleHumansMaleMiddle AgedRadiomicsRetrospective StudiesROC CurveCOVID‐19elderlymiddle‐agednomogrampneumoniatomographyX‐ray computed

Identifiers

PMID39611805
PMCPMC11995421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.